# 6328
As I’ve mentioned previously, once a month the CDC presents a Public Health Grand Rounds webcast, that focuses on a single public health issue. In April of last year I gave considerable blog space to CDC Grand Rounds: Sodium Reduction.
Later today (1 pm EDT) the CDC will live stream their latest Grand Rounds presentation, this time on the growing threat of multi-drug resistant gonorrhea.
Tuesday, May 15, 2012 1 p.m. – 2 p.m., EDT
This is a subject that both Maryn McKenna (see Drug-Resistant Gonorrhea: How We Lost Track and The Clap Came Back: Multidrug-Resistant Gonorrhea) and I have written about in the past.
A couple of my offerings include:
The Path Of Increased Resistance
True in the 1940s, but sadly, no longer the case – Photo Credit scdhec.gov
and . . .
Going, Going, Gonorrhea
Here is the CDC’s announcement for today’s Grand Rounds:
Public Health Grand Rounds
The Growing Threat of Multidrug-Resistant Gonorrhea
This session of Grand Rounds will explore the development of antibiotic resistance in Neisseria gonorrhoeae as a growing public health concern because the United States gonorrhea control strategy relies on effective antibiotic therapy. Since antibiotics were first used for treatment of gonorrhea, N. gonorrhoeae has progressively developed resistance to the antibiotic drugs prescribed to treat it: sulfonilamides, penicillin, tetracycline, and ciprofloxacin. Currently, CDC STD treatment guidelines recommend dual therapy with a cephalosporin antibiotic (ceftriaxone is preferred) and either azithromycin or doxycycline to treat all uncomplicated gonococcal infections among adults and adolescents in the United States.
Given the ability of N. gonorrhoeae to develop antibiotic resistance, it is critical to continuously monitor gonococcal antibiotic resistance and encourage research and development of new treatment regimens for gonorrhea.
Today’s presenters include:
Edward Hook III, MD
Professor of Medicine and Epidemiology
University of Alabama, BirminghamWilliam Shafer, PhD
Professor of Microbiology and Immunology
Emory UniversityCarolyn Deal, PhD
Chief, Sexually Transmitted Diseases Branch
National Institute of Allergy and Infectious Diseases
National Institutes of HealthRobert D. Kirkcaldy, MD, MPH
Medical Officer
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
If you miss the live broadcast, you’ll be able to view this latest Grand Rounds presentation on the CDC’s Streaming Health Youtube Channel in about 48 hours.
